Grit Biotechnology
San Diego, United States· Est.
Grit Biotechnology is developing engineered cell therapies for oncology, focusing on enhancing T cell persistence and function.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $60M
About
Grit Biotechnology is developing engineered cell therapies for oncology, focusing on enhancing T cell persistence and function.
OncologyCell Therapy
Funding History
1Total raised:$60M
Series B$60M